Cargando…

HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8(+) T Cell-Mediated Immune Response

We developed an innovative strategy to induce a cytotoxic T cell (CTL) immune response against protein antigens of choice. It relies on the production of exosomes, i.e., nanovesicles spontaneously released by all cell types. We engineered the upload of huge amounts of protein antigens upon fusion wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Bonito, Paola, Ridolfi, Barbara, Columba-Cabezas, Sandra, Giovannelli, Andrea, Chiozzini, Chiara, Manfredi, Francesco, Anticoli, Simona, Arenaccio, Claudia, Federico, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379561/ https://www.ncbi.nlm.nih.gov/pubmed/25760140 http://dx.doi.org/10.3390/v7031079

Ejemplares similares

The CD8(+) T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant
por: Manfredi, Francesco, et al.
Publicado: (2016)

Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation
por: Di Bonito, Paola, et al.
Publicado: (2017)

Cell activation and HIV-1 replication in unstimulated CD4(+) T lymphocytes ingesting exosomes from cells expressing defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2014)

Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1
por: Arenaccio, Claudia, et al.
Publicado: (2015)

The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells
por: Ferrantelli, Flavia, et al.
Publicado: (2019)

N-Terminal Fatty Acids of NEF(MUT) Are Required for the CD8(+) T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2020)

Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases
por: Ferrantelli, Flavia, et al.
Publicado: (2020)

Simultaneous CD8(+) T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

Long-Term Antitumor CD8(+) T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
por: Ferrantelli, Flavia, et al.
Publicado: (2021)

The C-Terminal Domain of Nef(mut) Is Dispensable for the CD8(+) T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
por: Chiozzini, Chiara, et al.
Publicado: (2021)

Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
por: Manfredi, Francesco, et al.
Publicado: (2022)

Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
por: Di Bonito, Paola, et al.
Publicado: (2019)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation
por: Olivetta, Eleonora, et al.
Publicado: (2014)

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver
por: Marcus, Michelle E., et al.
Publicado: (2013)

Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
por: Zhu, Xiaolan, et al.
Publicado: (2019)

Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression
por: Kase, Yutaro, et al.
Publicado: (2021)

A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis
por: Cui, Yongzhi, et al.
Publicado: (2021)

Hypocapnia Stimuli-Responsive Engineered Exosomes Delivering miR-218 Facilitate Sciatic Nerve Regeneration
por: Wang, Yingshuai, et al.
Publicado: (2022)

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis
por: Guenat, David, et al.
Publicado: (2017)

Molecular and Functional Profiles of Exosomes From HPV(+) and HPV(−) Head and Neck Cancer Cell Lines
por: Ludwig, Sonja, et al.
Publicado: (2018)

Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8(+) T lymphocyte exhaustion
por: Ascione, Alessandro, et al.
Publicado: (2019)

The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics
por: Yang, Mengliu, et al.
Publicado: (2018)

Proteomes of exosomes from HPV(+) or HPV(-) head and neck cancer cells: differential enrichment in immunoregulatory proteins
por: Ludwig, Sonja, et al.
Publicado: (2019)

Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series
por: Balestrieri, Maria, et al.
Publicado: (2023)

The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects?
por: Yin, Tianwen, et al.
Publicado: (2021)

Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases
por: Mori, Tosca, et al.
Publicado: (2023)

Using expert-elicitation to deliver biodiversity monitoring priorities on a Mediterranean island
por: Peyton, J., et al.
Publicado: (2022)

Exosomes: Emerging Modulators of Pancreatic Cancer Drug Resistance
por: Di Donato, Marzia, et al.
Publicado: (2023)

Exosome-delivered microRNAs modulate the inflammatory response to endotoxin
por: Alexander, Margaret, et al.
Publicado: (2015)

Engineering Exosomes for Cancer Therapy
por: Gilligan, Katie E., et al.
Publicado: (2017)

Biodistribution of Exosomes and Engineering Strategies for Targeted Delivery of Therapeutic Exosomes
por: Choi, Hojun, et al.
Publicado: (2021)

Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
por: Paolini, Francesca, et al.
Publicado: (2021)

Sex-Dependent Outcome of Hepatitis B and C Viruses Infections: Synergy of Sex Hormones and Immune Responses?
por: Ruggieri, Anna, et al.
Publicado: (2018)

Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs
por: Amici, Carla, et al.
Publicado: (2020)

Delivering effectively on large engineering projects
por: Madhavan, Guru, et al.
Publicado: (2023)

Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor
por: Wang, Shijie, et al.
Publicado: (2017)

Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania
por: Watson-Jones, Deborah, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a7c2h16cepgtlvpasndg83eurj